Testing the Addition of an Anti-cancer Drug, BAY 1895344, to Usual Chemotherapy for Advanced Stage Solid Tumors, With a Specific Focus on Patients With Small Cell Lung Cancer, Poorly Differentiated Neuroendocrine Cancer, and Pancreatic Cancer
ACTIVE_NOT_RECRUITING
Status
Conditions
- Metastatic Lung Small Cell Carcinoma
- Metastatic Malignant Solid Neoplasm
- Metastatic Neuroendocrine Carcinoma
- Metastatic Pancreatic Adenocarcinoma
- Stage III Lung Cancer AJCC v8
- Stage III Pancreatic Cancer AJCC v8
- Stage IV Lung Cancer AJCC v8
- Stage IV Pancreatic Cancer AJCC v8
- Unresectable Lung Small Cell Carcinoma
- Unresectable Malignant Solid Neoplasm
- Unresectable Neuroendocrine Carcinoma
- Unresectable Pancreatic Adenocarcinoma
Interventions
- PROCEDURE: Biopsy
- PROCEDURE: Biospecimen Collection
- PROCEDURE: Computed Tomography
- DRUG: Elimusertib
- DRUG: Irinotecan Hydrochloride
- PROCEDURE: Magnetic Resonance Imaging
- DRUG: Topotecan Hydrochloride
Sponsor
National Cancer Institute (NCI)